MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling.
Gang WangYulin LuoXiaojun GaoYu LiangFeifei YangJianbo WuDan FangMao LuoPublished in: Cellular and molecular life sciences : CMLS (2023)
Alterations in the vascular smooth muscle cells (VSMC) phenotype play a critical role in the pathogenesis of several cardiovascular diseases, including hypertension, atherosclerosis, and restenosis after angioplasty. MicroRNAs (miRNAs) are a class of endogenous noncoding RNAs (approximately 19-25 nucleotides in length) that function as regulators in various physiological and pathophysiological events. Recent studies have suggested that aberrant miRNAs' expression might underlie VSMC phenotypic transformation, appearing to regulate the phenotypic transformations of VSMCs by targeting specific genes that either participate in the maintenance of the contractile phenotype or contribute to the transformation to alternate phenotypes, and affecting atherosclerosis, hypertension, and coronary artery disease by altering VSMC proliferation, migration, differentiation, inflammation, calcification, oxidative stress, and apoptosis, suggesting an important regulatory role in vascular remodeling for maintaining vascular homeostasis. This review outlines recent progress in the discovery of miRNAs and elucidation of their mechanisms of action and functions in VSMC phenotypic regulation. Importantly, as the literature supports roles for miRNAs in modulating vascular remodeling and for maintaining vascular homeostasis, this area of research will likely provide new insights into clinical diagnosis and prognosis and ultimately facilitate the identification of novel therapeutic targets.
Keyphrases
- oxidative stress
- cardiovascular disease
- smooth muscle
- vascular smooth muscle cells
- coronary artery disease
- blood pressure
- signaling pathway
- systematic review
- transcription factor
- type diabetes
- heart failure
- cell proliferation
- gene expression
- ischemia reperfusion injury
- induced apoptosis
- metabolic syndrome
- cardiovascular risk factors
- cardiovascular events
- percutaneous coronary intervention
- genome wide analysis